A2 Bio
Developer of a cell therapy designed to cure cancer via tumor-specific targeting. The company engineers tumor cells that target the loss of genetic material in tumors through the selective killing of ...
Valuation
$280M
Market implied
Share Price
N/A
Total Raised
$352.9M
Last Round
N/A